World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
110
Citations
69117
World Ranking
871
National Ranking
527

Medicine

D-Index
111
Citations
72547
World Ranking
5233
National Ranking
2825

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Laura J. van't Veer is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, and Pulmonary and Respiratory Medicine.

Their scholarly work focuses on several core topics within cancer research and treatment. Key areas include Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics, Medical Imaging Techniques and Applications, MRI in cancer diagnosis, and Advanced Breast Cancer Therapies.

Frequent co-authors collaborating with Laura J. van't Veer include:

  • Laura J. Esserman
  • Christina Yau
  • Nola M. Hylton
  • Hope S. Rugo
  • Claudine Isaacs

The scientist has published extensively in several venues, with the most frequent publication outlets being:

  • Cancer Research
  • Annals of Oncology
  • UNC Libraries
  • Breast Cancer Research and Treatment
  • npj Breast Cancer

Recent notable papers authored or co-authored by Laura J. van't Veer include:

  • "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial," 2021, Cancer Cell
  • "Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer," 2020, JAMA Oncology
  • "MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial," 2020, Journal of Clinical Oncology
  • "ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer," 2023, Proceedings of the National Academy of Sciences
  • "Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer," 2021, npj Breast Cancer

Best Publications

  • Gene expression profiling predicts clinical outcome of breast cancer

    Laura J. van 't Veer;Hongyue Dai;Marc J. van de Vijver;Yudong D. He

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

    Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Concordance among Gene-Expression–Based Predictors for Breast Cancer

    Cheng Fan;Daniel S Oh;Lodewyk Wessels;Britta Weigelt

  • Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

    Katherine A. Hoadley;Christina Yau;Denise M. Wolf;Andrew D. Cherniack

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

    Miranda L. Broz;Mikhail Binnewies;Bijan Boldajipour;Amanda E. Nelson

  • Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

    Howard Y. Chang;Dimitry S. A. Nuyten;Julie B. Sneddon;Trevor Hastie

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • A common coding variant in CASP8 is associated with breast cancer risk

    Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian

  • Enabling personalized cancer medicine through analysis of gene-expression patterns

    Laura J. van 't Veer;René Bernards

  • Refinement of breast cancer classification by molecular characterization of histological special types.

    B Weigelt;H M Horlings;B Kreike;M M Hayes

  • Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Ramon Salazar;Paul Roepman;Gabriel Capella;Victor Moreno

  • Converting a breast cancer microarray signature into a high-throughput diagnostic test.

    Annuska M. Glas;Arno Floore;Leonie Jmj M. J. Delahaye;Anke T. Witteveen

  • Gene expression profiles of primary breast tumors maintained in distant metastases.

    Britta Weigelt;Annuska M. Glas;Lodewyk F. A. Wessels;Anke T. Witteveen

  • Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau

  • Clinical application of the 70-gene profile: the MINDACT trial.

    Fatima Cardoso;Laura Van't Veer;Emiel Rutgers;Sherene Loi

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Christina Yau
Christina Yau University of California, San Francisco
Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Angela DeMichele
Angela DeMichele University of Pennsylvania
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Douglas F. Easton
Douglas F. Easton University of Cambridge
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a variety of online healthcare degrees and certifications. For those seeking to advance their clinical expertise, best online dnp programs offer flexible, high-level nursing training that prepares practitioners for leadership roles.

Pharmacy professionals can benefit from affordable distance education options as well. While evaluating online pharmacy school cost, students can find accessible programs that fit a range of budgets and schedules.

Not all healthcare careers are patient-facing. Administrative and information sectors are growing rapidly. Earning credentials from rhia certification programs online can lead to in-demand roles managing medical data and compliance.

If you’re interested in insurance or healthcare finance, attaining a recognized qualification through an affordable medical billing and coding certification cost can quickly open new career opportunities in this vital field.

Best Scientists Citing Laura J. van't Veer

Trending Scientists

Recently Published Articles